small molecule glp 1 agonist Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies In the ACHIEVE-1 phase 3
Description
New and existing patients will automatically receive the $449 offer on their first purchase of the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses
doi: 10.1124/jpet.106.100982
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
Zhao, W., Zhang, X., Zhou, Z., Sun, B., Gu, W., Liu, J., & Zhang, H
( 10.1001/jama.2023.24945) [DOI] [PMC free article] [PubMed] [Google Scholar] Ast J, Arvaniti A, Fine NHF, Nasteska D, Ashford FB, Stamataki Z, Koszegi Z, Bacon A, Jones BJ, Lucey MA, et al
The American Diabetes Association Standards of Care advises caution when using these agents in patients with gastroparesis
